Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma.
Nayer
Hassan
H
Murphy
Kathleen M
KM
Hawkins
Anita L
AL
Long
Patricia P
PP
Gillison
Maura
M
Borowitz
Michael
M
Griffin
Constance A
CA
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002869:Chromosome Aberrations; D003582:Cytogenetics / Q000379:methods; D003713:Dendritic Cells / Q000378:metabolism*; D017809:Fatal Outcome; D006801:Humans; D007150:Immunohistochemistry; D007621:Karyotyping; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics*; D012509:Sarcoma / Q000188:drug therapy* / Q000235:genetics*; D013365:Submandibular Gland Neoplasms / Q000188:drug therapy* / Q000235:genetics*
D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2